SCHEMBL6324644

SCHEMBL6324644

Nc1cccc(Nc2ncccc2C(=O)O)c1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHODH Q02127 8/20 0.72
MEN1 O00255 8/20 0.67
KMT2A Q03164 8/20 0.67
LMNA P02545 5/20 0.67
ALDH1A1 P00352 4/20 0.67
PKM P14618 2/20 0.67
HTT P42858 2/20 0.67
MAPK1 P28482 1/20 0.67
GMNN O75496 1/20 0.67
TTR P02766 1/20 0.67
CYP1A2 P05177 1/20 0.67
CYP3A4 P08684 1/20 0.67
CYP2C9 P11712 1/20 0.67
NFKB1 P19838 1/20 0.67
UGT1A1 P22309 1/20 0.67
PTGS1 P23219 1/20 0.67
PTGS2 P35354 1/20 0.67
PMP22 Q01453 1/20 0.67
TEAD4 Q15561 1/20 0.67
HIF1A Q16665 1/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6332639 0.85 MEN1 (0.60) DHODHMEN1KMT2ALMNAALDH1A1
SCHEMBL479877 0.84 DHODH (1.00) DHODHMEN1KMT2ALMNAALDH1A1
SCHEMBL15636690 0.84 LMNA (0.78) DHODHMEN1KMT2ALMNAALDH1A1
SCHEMBL10144303 0.84 MEN1 (0.71) DHODHMEN1KMT2ALMNAALDH1A1
SCHEMBL4905983 0.84 DHODH (0.72) DHODHMEN1KMT2ALMNAALDH1A1
SCHEMBL3455093 0.82 MEN1 (0.67) DHODHMEN1KMT2ALMNAALDH1A1
Niflumic Acid SCHEMBL4886924 0.81 DHODH (1.00) DHODHMEN1KMT2ALMNAALDH1A1
Niflumic Acid SCHEMBL29364001 0.81 DHODH (1.00) DHODHMEN1KMT2ALMNAALDH1A1
Niflumic Acid SCHEMBL24706 0.81 DHODH (1.00) DHODHMEN1KMT2ALMNAALDH1A1
SCHEMBL5256676 0.81 MEN1 (0.65) DHODHMEN1KMT2ALMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050124664-A1 Urea thiadiazole inhibitors of plasminogen activator inhibior-1 BRISTOL-MYERS SQUIBB CO. 2005-06-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050124664-A1 Urea thiadiazole inhibitors of plasminogen activator inhibior-1 SERPINE1, SERPINC1, SERPINB1 DHODH 1220/4885MEN1 1004/4885KMT2A 4128/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.